Antidepressant Effect of Mood Stabilizers

CNS Spectrums

Volumn 8, Issue S12, 2003, Pages 4-5

  Baldassano, Claudia F ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85011498364     PISSN: 10928529     EISSN: 21656509     Source Type: Journal    
DOI: 10.1017/S1092852900028777     Document Type: Article

References (14)

1. Judd, LL, HS, Akiskal. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database caking into account sub-threshold cases. J Affect Disord. 2003; 73(1–2):123–131.
2. Hirschfeld, RA, Bowden, CL, Gitlin, MJ, et al. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002; 159: 1–50.
3. Zornberg, GL, Pope, HG Jr. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol. 1993; 13: 397–408.
4. Goodwin, FK, KR, Jamison. Manic-Depressive Illness. New York, NY: Oxford University Press, Inc; 1990.
5. Nemeroff, CB, Evans, DL, Gyulai, L, et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry. 2001; 158: 906–912.
6. Baldessarini, RJ, Tondo, L, Hennen, J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry. 1999; 60(suppl 2):77–84.
7. Goodwin, FK, Fireman, F, Simon, GE, Hunkeler, EM, Lee, J, Revicki, D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003; 11: 1467–1473.
8. Calabrese, JR, Bowden, CL, Sachs, GS, Ascher, JA, Monaghan, E, GD, Rudd. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry, 1999; 60: 79–88.
9. Frye, MA, Ketter, TA, Kimbrell, TA, et al. A placebo-controlled study of lamotrig-ine and gabapentin monothetapy in refractory mood disorders. J Clin Psychopharmacol. 2000; 20: 607–614.
10. McElroy, SL, Keck, PE Jr., HG, Pope Jr., JI, Hudson. Valproate in psychiatric disorders: literature review and clinical guidelines. J Clin Psychiatry. 1989; 50(supp 1):23–29.
11. PA, Lambert. Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). In: Emtich, HM, Okuma, T, Muller, AA, eds. Anticonvulsants in Affective Disorders. Amsterdam: Elsevier Science Publishers; 1984: 33–44.
12. Sachs, G. Divalproex monotherapy in bipolar depression. Poster presented at: Annual Meeting of the American College of Neuropsychopharmacology; 12, 2001; San Juan, Puerto Rico.
13. Young, LT, Joffe, RT, Robb, JC, MacQueen, GM, Marriott, M, Patelis-Siotis, I. Double -blind comparison of addition of a second mood stabilizer versus an anti-depressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry. 2000; 157: 124–126.
14. McIntyre, RS, Mancini, DA, McCann, S, Srinivasan, J, Sagman, D, Kennedy, D. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord. 2002; 3: 207–213.